Science & Strategy at the World Orphan Drug Congress

 

Strategy, advocacy and partnering for the orphan drug industry

2-5 November 2020

Melia Sitges Hotel Resort, Barcelona, Spain

 

 
700+
Attendees
350+
Companies
200+
Speakers
80%
Decision Makers
2
Co-located events

Precision Medicine

 

➤  Exploring the use of genomics, artificial intelligence and machine learning to help bring an end to the diagnostic odyssey

➤  Discovery Diagnostics

➤  Digital Health

➤  Apps for patients

➤  Apps for patients

➤  Precision medicine approaches for orphan diseases (alternatives to cell & gene therapy)

2019 KEY SPEAKERS

 

Joanne Hackett , Chief Commercial Officer , Genomics England

Joanne Hackett | Chief Commercial Officer | Genomics England » speaking at Orphan Drug Congress

Philip Nelson , Director, Software Engineering , Google Inc

Philip Nelson | Director, Software Engineering | Google Inc » speaking at Orphan Drug Congress

Julian Isla , Data And Artificial Intelligence Resource Manager , Microsoft Corp

Julian Isla | Data And Artificial Intelligence Resource Manager | Microsoft Corp » speaking at Orphan Drug Congress

Ryan Taft , Vice President for Scientific Research , Illumina

Ryan Taft | Vice President for Scientific Research | Illumina » speaking at Orphan Drug Congress

Krishnan Nandabalan , President And Chief Executive Officer , InveniAI Corporation

Krishnan Nandabalan | President And Chief Executive Officer | InveniAI Corporation » speaking at Orphan Drug Congress